News & Press Releases

Filter
444 found

MMV launches the Seasonal Malaria Chemoprevention Tool Kit

29 Apr 2014
Access & product management

GSK and MMV announce start of Phase III programme of tafenoquine

28 Apr 2014
R&D

MMV and Merck Serono join forces in antimalarial drug discovery

24 Feb 2014
Partner, R&D

MMV and partners call for compounds to fill the Pathogen Box

18 Feb 2014
Open source, R&D

Potential new antimalarial drug identified at the University of Dundee

06 Feb 2014
R&D
© iStock.com/combojan fatur

Takeda collaborates with MMV through GHIT Fund

24 Dec 2013
Partner

Breakthrough Therapy designation for potential new anti-relapse medicine for malaria

20 Dec 2013
Access & product management, R&D

Tafenoquine successfully completes Phase IIb clinical trials

19 Dec 2013
R&D

State-of-the-art laboratory to study new antimalarials opens in Jakarta

10 Dec 2013
R&D

Rise in R&D funding could set the stage for malaria eradication

10 Dec 2013
General

New antimalarial drug target identified

29 Nov 2013
R&D

Partners commit to bolstering open source research

27 Nov 2013
Open source, R&D

MMV signs MoU with Takeda and GHIT (Japan)

11 Nov 2013
R&D

MMV partner receives PLOS Accelerating Science Award

23 Oct 2013
Open source, R&D

First-ever drug compound developed on African soil, an antimalarial, to move to human trials

08 Oct 2013
R&D

Eurartesim® begins ‘real-life’ post African registration safety and effectiveness testing

03 Oct 2013
Access & product management

Campaign launched to help eliminate malaria deaths

23 Sep 2013
General

MMV’s ‘Challenge Model’ creates a buzz in Australia

16 Sep 2013
R&D

Potential new class of antimalarials now open source

10 Sep 2013
R&D, Open source

MMV receives funding to develop drugs to accelerate malaria eradication

22 Aug 2013
Donors

DFID pledges further support for MMV

22 Aug 2013
Donors

Australian first to advance malaria medicines

19 Aug 2013
Donors

African research is rising

12 Jul 2013
R&D

Japan launches bold effort to fight neglected diseases

31 May 2013
R&D

WHO approves injectable artesunate 30mg & 120mg

24 May 2013
Access & product management

MMV welcomes appointment of UK MP as Global Advocate for Malaria

17 May 2013
General

MMV and WHO launch new malaria map tool

25 Apr 2013
Access & product management, General

World Malaria Day 2013

25 Apr 2013
General

Winners of malaria photo contest announced

22 Apr 2013
General

Japan’s First PPP to Spearhead Innovation in Global Health

08 Apr 2013
General

Malaria in Brazil: David Reddy interviewed by Brazilian Society of Tropical Medicine

04 Apr 2013
General

Who will win ‘Malaria: The BIG picture’ contest: you decide!

25 Mar 2013
General

Quinolones: breathing new life into an old class of compounds to tackle malaria

20 Mar 2013
R&D

US policy and funding landscape for global health R&D in 2013 and beyond

15 Mar 2013
General

Eurartesim® (dihydroartemisinin-piperaquine) registered in first African country

07 Mar 2013
Access & product management

Ray Chambers appointed by UN to step-up financing for health related-MDGs

06 Mar 2013
General

New pack for Injectable Artesunate (InjAS) accepted by WHO Prequalification

25 Feb 2013
Access & product management

Salt pumps: A chink in the malaria parasite’s armour

21 Feb 2013
R&D

Malaria: The BIG Picture

15 Feb 2013
General

James Cochrane to receive Queen’s New Year honour

08 Jan 2013
General

MMV and partners handover SMS for Life in Tanzania to Government

07 Jan 2013
Access & product management

Malaria funding falls short by half

18 Dec 2012
General

MMV to advance WHO-TDR’s pioneering studies on intrarectal artesunate

14 Dec 2012
Access & product management

Focusing on malaria drug discovery

13 Dec 2012
R&D

UNITAID awards MMV-led consortium up to US$ 34 million

11 Dec 2012
Access & product management

Open access initiative reveals drug hits for deadly neglected tropical diseases

13 Nov 2012
R&D, Open source

Eurartesim® awarded MMV Project of the Year 2011

12 Nov 2012
General

Drawing attention to malaria

25 Oct 2012
General

Momentum builds for neglected diseases drug discovery

21 Sep 2012
R&D

Improving safety for antimalarial drugs

31 Aug 2012
R&D

African antimalarial research bears first fruit

28 Aug 2012
R&D

New medicine for relapsing malaria being evaluated in four countries

27 Aug 2012
R&D

MMV assesses risk of resistance

22 Aug 2012
R&D

Eurartesim® reaches Cambodia

19 Jul 2012
Access & product management

MMV supports Asia Pacific malaria forum

19 Jul 2012
General

MMV and the European Bioinformatics Institute establish one-stop shop for malaria drug data

13 Jul 2012
R&D, Open source

Scaling-up access to life-saving antimalarials in Nigeria

11 Jul 2012
Access & product management

OZ439 clears the first clinical development hurdle

11 Jul 2012
R&D

Pyronaridine/artesunate included in the list of WHO prequalified medicines

15 May 2012
Access & product management

MMV’s Chief Scientific Officer elected to Academy of Medical Sciences

10 May 2012
General

Pages